首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3273篇
  免费   156篇
  国内免费   71篇
儿科学   123篇
妇产科学   107篇
基础医学   537篇
口腔科学   3篇
临床医学   131篇
内科学   148篇
皮肤病学   4篇
神经病学   17篇
特种医学   48篇
外科学   1571篇
综合类   314篇
预防医学   110篇
眼科学   2篇
药学   178篇
中国医学   39篇
肿瘤学   168篇
  2023年   14篇
  2022年   21篇
  2021年   66篇
  2020年   65篇
  2019年   71篇
  2018年   53篇
  2017年   65篇
  2016年   63篇
  2015年   67篇
  2014年   139篇
  2013年   155篇
  2012年   105篇
  2011年   125篇
  2010年   123篇
  2009年   156篇
  2008年   168篇
  2007年   168篇
  2006年   177篇
  2005年   143篇
  2004年   167篇
  2003年   118篇
  2002年   132篇
  2001年   107篇
  2000年   93篇
  1999年   67篇
  1998年   71篇
  1997年   57篇
  1996年   51篇
  1995年   60篇
  1994年   42篇
  1993年   39篇
  1992年   30篇
  1991年   32篇
  1990年   37篇
  1989年   43篇
  1988年   45篇
  1987年   38篇
  1986年   38篇
  1985年   39篇
  1984年   31篇
  1983年   28篇
  1982年   38篇
  1981年   39篇
  1980年   28篇
  1979年   13篇
  1978年   41篇
  1977年   6篇
  1976年   14篇
  1975年   6篇
  1974年   3篇
排序方式: 共有3500条查询结果,搜索用时 31 毫秒
1.
2.
3.
Xanthogranulomatous orchitis is an extremely rare inflammatory non-neoplastic destructive lesion of the testis. We report a 44-year-old man who presented with right scrotal swelling and two discharging sinuses. Testicular tumor markers were normal. Scrotal ultrasound showed heterogeneous testicular areas and irregular margin of the tunica. Surgical exploration revealed infected, unhealthy testicular tissue with necrosis and tumor-like lesion. Orchidectomy was done and histopathology showed xanthogranulomatous orchitis.  相似文献   
4.
OBJECTIVE: Standard chemotherapy shows relatively low long-term survival in patients with poor-risk testicular germ cell tumor (GCT). First-line high-dose chemotherapy (HD-CT) may improve the result. High-dose carboplatin, etoposide, ifosfamide chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) was investigated as first-line chemotherapy in patients with advanced testicular GCT. METHODS: Fifty-five previously untreated testicular GCT patients with Indiana 'advanced disease' criteria received three cycles of bleomycin, etoposide and cisplatin (BEP) followed by one cycle of HD-CT plus PBSCT, if elevated serum tumor markers were observed after three cycles of the BEP regimen. RESULTS: Thirty patients were treated with BEP alone, because the tumor marker(s) declined to normal range. Twenty-five patients received BEP and HD-CT. One patient died of rhabdomyolysis due to HD-CT. Three and six (13% and 25%) out of 24 patients treated with BEP and HD-CT achieved marker-negative and marker-positive partial responses, respectively. The other patients achieved no change. Fifteen (63%) are alive and 14 (58%) are free of disease at a median follow-up time of 54 months. Severe toxicity included treatment-related death (4%). CONCLUSIONS: HD-CT with peripheral stem cell support can be successfully applied in a multicenter setting. HD-CT demonstrated modest anticancer activity for Japanese patients with advanced testicular GCT and was well tolerated. This regimen might be examined for further investigation in randomized trials in first-line chemotherapy for patients with poor-risk testicular GCT.  相似文献   
5.
对小鼠睾丸冰冻切片LDH-X的显示方法作了进一步探讨。实验表明,以L-2-羟基-3-甲基戊酸(HMV)为特异性底物,能相当有效地显示睾丸LDH-X的分布,且该底物的配制方法简便易行。在显示LDH-X的孵育液中采用萘酚蓝(NB)作中间递电子体较吩嗪甲基硫酸酯更具优越性。  相似文献   
6.
Homologous testis transplantation in dogs   总被引:4,自引:0,他引:4  
There is growing interest in the possible use of homologous testis transplantation for the treatment of anorchia and male infertility. In order to test the surgical and immunological feasibility of this therapy, three series of experimental studies of homologous testis transplantation were carried out in dogs. In the first pilot study, four beagles from the same litter were transplanted using microsurgical techniques for end-to-end anastomosis of the testicular vessels and the vas deferens. These dogs received cyclosporin A (CyA) for 3 months after transplantation. The longest functional graft survival in this series was 163 days, strongly suggesting that long-term survival of a homologously transplanted testis graft is possible. A second series of operations was performed on ten mongrel dogs. The same surgical technique was employed and the series was divided into three groups. Group 1 received CyA monotherapy, group 2 a combination of CyA and prednisolone, and group 3 received no immunosuppression. The average graft survival time in this series was 18 days, significantly less than the 71 days in the first series. The dogs in group 2, however, had graft survival times that were three times longer than those in the other two groups, suggesting that CyA in combination with prednisolone yields the best graft survival. In the third series, five littermates received a testis graft after castration. Immunosuppression was achieved by administration of CyA and prednisolone for 3 months. In three out of five animals, the graft survived until the immunosuppressive therapy was suspended. Histological biopsies of the graft 3 months after transplantation showed the same maturation of sperm cells as in the control testis of the same dog. The results of the last series suggest that long-term survival of homologously transplanted testis grafts in dogs is, indeed, possible with the aid of CyA and prednisolone. Received: 14 August 1996 Received after revision: 21 March 1997 Accepted: 24 April 1997  相似文献   
7.
Torsions of the spermatic cord occurring from the intrauterine period to the end of the first year of life are termed perinatal. These are divided into prenatal and postnatal torsions, depending on their occurrence in the intrauterine or postuterine period. From January 1984 to January 1996, 6 cases were identified at our institution, involving 4 prenatal and 2 postnatal extravaginal torsions of the spermatic cord. These cases are reviewed with regard to optimal therapeutic approaches for the treatment of both the affected gonad as well as the contralateral one, and whether the event occurred prenatally or postnatally. The authors also propose several clinical indications useful for obstetricians, pediatricians, urologists and nurses.  相似文献   
8.
Prof. Dr.  O. P. Steeno 《Andrologia》1989,21(2):103-112
Summary: For the quantitative determination of the testicular size or volume, two groups of apparatus are available: on the one hand, model testes, which are extremely valuable in longitudinal and cross-sectional studies during the period of pubescence, and on the other hand, measuring devices, with which the testicular dimensions can be specified. The latter instruments are helpful chiefly during the adolescent years and the diagnosis of problems surrounding fertility. The testicular volume can be calculated subsequently from the specific testicular measurements. The formula, for computing the volume of an ellipsoid, seems to be the most suitable for this purpose. Appliances also have been developed, which allow the largest (longitudinal) dimension (in mm) and the testicular volume (in cm3) to be read off simultaneously. A tonometer can be useful to quantitatively estimate the testicular consistency, which is a parameter of the testicular integrity at the level of tubular function (spermatozoa production).  相似文献   
9.
目的:认识睾丸微石症(TM)的临床意义和诊断方法。方法:回顾性报告2例TM病例的临床资料,结合文献进行讨论。结果:2例分别因左精索静脉曲张和附睾炎就诊的患者行阴囊超声检查时发现睾丸内散在多发点状强回声,如针尖样,1~2mm,后无声影。分别诊断为局部TM、左精索静脉曲张和TM,左附睾炎。甲胎蛋白、人绒毛膜促性腺激素、乳酸脱氢酶和睾酮等检查均正常。对睾丸微石症未做特殊处置,随访6~8个月,体检和睾丸瘤标未见异常,阴囊超声睾丸图像无特征性改变。结论:TM是一种少见、无明显临床症状、相对稳定的疾病。多因阴囊其他疾病行超声检查时偶然发现,其是否属于癌前病变尚有争议,但是定期随访和阴囊超声检查是必要的。  相似文献   
10.
目的:比较4种鹿藿根提取物(乙醇提取物、乙酸乙酯提取物、正丁醇提取物及水溶物)的抗生育作用。方法:60只雄性昆明种小鼠分为生理盐水对照组、雷公藤多苷对照组、乙醇提取物组、乙酸乙酯提取物组、正丁醇提取物组及水溶物组,每组10只。各组药物浓度均为1%,雷公藤多苷为0.1%水溶液。每次0.1ml/10g,灌胃,1次/d,连续给药,共11周。在用药10周后,一对一雌雄合笼交配1周。分笼10d后处死雌鼠,观察妊娠率、活胎数、死胎数。11周后处死雄性小鼠观察附睾精子、附睾及睾丸病理变化情况及血清睾酮含量测定。结果:连续用药11周,与生理盐水对照组相比,实验组小鼠妊娠率下降,其中水溶物组最为明显(P<0.05)。雷公藤多苷对照组和水溶组精子明显减少(P<0.05)。组织学观察鹿藿根提取物对精原细胞、初级精母细胞影响不显著。各提取物组血清睾酮差异无显著性(P>0.05)。生理盐水对照组、雷公藤多苷对照组、乙酸乙酯提取物组、正丁醇提取物组、乙醇提取物组及水溶物组的抗精子发生效应积分分别0、(5.3±1.5)、(2.6±1.7)、(2.9±1.2)、(2.2±0.9)、(2.1±1.0)分。结论:4种鹿藿根提取物均有抗生育作用,但水溶物作用更强且对睾丸组织及睾丸生精能力影响较小。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号